All data are based on the daily closing price as of January 23, 2026
t

T&L

340570.KQ
35.30 USD
-0.06
-0.17%

Overview

Last close
35.30 usd
Market cap
284.97M usd
52 week high
58.00 usd
52 week low
35.15 usd
Target price
57.11 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
2.1539
Price/Book Value
2.1186
Enterprise Value
225.69M usd
EV/Revenue
1.7058
EV/EBITDA
4.7954

Key financials

Revenue TTM
132.31M usd
Gross Profit TTM
58.21M usd
EBITDA TTM
45.38M usd
Earnings per Share
N/A usd
Dividend
0.54 usd
Total assets
154.06M usd
Net debt
N/A usd

About

T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was founded in 1998 and is headquartered in Yongin-si, South Korea.
  • Symbol
    340570.KQ
  • Exchange
    KQ
  • Isin
    KR7340570001
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Medical Devices
  • CEO
  • Headquarter
    Yongin-si
  • Web site
    https://www.tnl.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top